GFAP and Parkinson disease: In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse models, caffeine administration reversed striatal dopamine (DA) depletion, improved motor coordination, and reduced the number of MPTP-induced glial fibrillary acidic protein (GFAP)-positive cells.